The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians

BACKGROUND:The WHO recommends single low-dose primaquine (SLDPQ, 0.25 mg/kg body weight) in falciparum-infected patients to block malaria transmission and contribute to eliminating multidrug resistant Plasmodium falciparum from the Greater Mekong Sub region (GMS). However, the anxiety regarding PQ-i...

Full description

Bibliographic Details
Main Authors: Dysoley, L, Kim, S, Lopes, S, Khim, N, Bjorges, S, Top, S, Huch, C, Rekol, H, Westercamp, N, Fukuda, M, Hwang, J, Roca-Feltrer, A, Mukaka, M, Menard, D, Taylor, W
Format: Journal article
Language:English
Published: BioMed Central 2019
_version_ 1797053432821972992
author Dysoley, L
Kim, S
Lopes, S
Khim, N
Bjorges, S
Top, S
Huch, C
Rekol, H
Westercamp, N
Fukuda, M
Hwang, J
Roca-Feltrer, A
Mukaka, M
Menard, D
Taylor, W
author_facet Dysoley, L
Kim, S
Lopes, S
Khim, N
Bjorges, S
Top, S
Huch, C
Rekol, H
Westercamp, N
Fukuda, M
Hwang, J
Roca-Feltrer, A
Mukaka, M
Menard, D
Taylor, W
author_sort Dysoley, L
collection OXFORD
description BACKGROUND:The WHO recommends single low-dose primaquine (SLDPQ, 0.25 mg/kg body weight) in falciparum-infected patients to block malaria transmission and contribute to eliminating multidrug resistant Plasmodium falciparum from the Greater Mekong Sub region (GMS). However, the anxiety regarding PQ-induced acute haemolytic anaemia in glucose-6-phosphate dehydrogenase deficiency (G6PDd) has hindered its use. Therefore, we assessed the tolerability of SLDPQ in Cambodia to inform national policy. METHODS:This open randomised trial of dihydroartemisinin-piperaquine (DHAPP) + SLDPQ vs. DHAPP alone recruited Cambodians aged ≥1 year with acute uncomplicated P. falciparum. Randomisation was 4:1 DHAPP+SLDPQ: DHAPP for G6PDd patients and 1:1 for G6PDn patients, according to the results of the qualitative fluorescent spot test. Definitive G6PD status was determined by genotyping. Day (D) 7 haemoglobin (Hb) concentration was the primary outcome measure. RESULTS:One hundred nine patients (88 males, 21 females), aged 4-76 years (median 23) were enrolled; 12 were G6PDd Viangchan (9 hemizygous males, 3 heterozygous females). Mean nadir Hb occurred on D7 [11.6 (range 6.4 ─ 15.6) g/dL] and was significantly lower (p = 0.040) in G6PDd (n = 9) vs. G6PDn (n = 46) DHAPP+SLDPQ recipients: 10.9 vs. 12.05 g/dL, Δ = -1.15 (95% CI: -2.24 ─ -0.05) g/dL. Three G6PDn patients had D7 Hb concentrations < 8 g/dL; D7-D0 Hbs were 6.4 ─ 6.9, 7.4 ─ 7.4, and 7.5 ─ 8.2 g/dL. For all patients, mean (range) D7-D0 Hb decline was -1.45 (-4.8 ─ 2.4) g/dL, associated significantly with higher D0 Hb, higher D0 parasitaemia, and receiving DHAPP; G6PDd was not a factor. No patient required a blood transfusion. CONCLUSIONS:DHAPP+SLDPQ was associated with modest Hb declines in G6PD Viangchan, a moderately severe variant. Our data augment growing evidence that SLDPQ in SE Asia is well tolerated and appears safe in G6PDd patients. Cambodia is now deploying SLDPQ and this should encourage other GMS countries to follow suit. TRIAL REGISTRATION:The clinicaltrials.gov reference number is NCT02434952 .
first_indexed 2024-03-06T18:43:39Z
format Journal article
id oxford-uuid:0dc318eb-9fce-4dfe-8b01-d505c70f3889
institution University of Oxford
language English
last_indexed 2024-03-06T18:43:39Z
publishDate 2019
publisher BioMed Central
record_format dspace
spelling oxford-uuid:0dc318eb-9fce-4dfe-8b01-d505c70f38892022-03-26T09:42:14ZThe tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected CambodiansJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:0dc318eb-9fce-4dfe-8b01-d505c70f3889EnglishSymplectic Elements at OxfordBioMed Central2019Dysoley, LKim, SLopes, SKhim, NBjorges, STop, SHuch, CRekol, HWestercamp, NFukuda, MHwang, JRoca-Feltrer, AMukaka, MMenard, DTaylor, WBACKGROUND:The WHO recommends single low-dose primaquine (SLDPQ, 0.25 mg/kg body weight) in falciparum-infected patients to block malaria transmission and contribute to eliminating multidrug resistant Plasmodium falciparum from the Greater Mekong Sub region (GMS). However, the anxiety regarding PQ-induced acute haemolytic anaemia in glucose-6-phosphate dehydrogenase deficiency (G6PDd) has hindered its use. Therefore, we assessed the tolerability of SLDPQ in Cambodia to inform national policy. METHODS:This open randomised trial of dihydroartemisinin-piperaquine (DHAPP) + SLDPQ vs. DHAPP alone recruited Cambodians aged ≥1 year with acute uncomplicated P. falciparum. Randomisation was 4:1 DHAPP+SLDPQ: DHAPP for G6PDd patients and 1:1 for G6PDn patients, according to the results of the qualitative fluorescent spot test. Definitive G6PD status was determined by genotyping. Day (D) 7 haemoglobin (Hb) concentration was the primary outcome measure. RESULTS:One hundred nine patients (88 males, 21 females), aged 4-76 years (median 23) were enrolled; 12 were G6PDd Viangchan (9 hemizygous males, 3 heterozygous females). Mean nadir Hb occurred on D7 [11.6 (range 6.4 ─ 15.6) g/dL] and was significantly lower (p = 0.040) in G6PDd (n = 9) vs. G6PDn (n = 46) DHAPP+SLDPQ recipients: 10.9 vs. 12.05 g/dL, Δ = -1.15 (95% CI: -2.24 ─ -0.05) g/dL. Three G6PDn patients had D7 Hb concentrations < 8 g/dL; D7-D0 Hbs were 6.4 ─ 6.9, 7.4 ─ 7.4, and 7.5 ─ 8.2 g/dL. For all patients, mean (range) D7-D0 Hb decline was -1.45 (-4.8 ─ 2.4) g/dL, associated significantly with higher D0 Hb, higher D0 parasitaemia, and receiving DHAPP; G6PDd was not a factor. No patient required a blood transfusion. CONCLUSIONS:DHAPP+SLDPQ was associated with modest Hb declines in G6PD Viangchan, a moderately severe variant. Our data augment growing evidence that SLDPQ in SE Asia is well tolerated and appears safe in G6PDd patients. Cambodia is now deploying SLDPQ and this should encourage other GMS countries to follow suit. TRIAL REGISTRATION:The clinicaltrials.gov reference number is NCT02434952 .
spellingShingle Dysoley, L
Kim, S
Lopes, S
Khim, N
Bjorges, S
Top, S
Huch, C
Rekol, H
Westercamp, N
Fukuda, M
Hwang, J
Roca-Feltrer, A
Mukaka, M
Menard, D
Taylor, W
The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians
title The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians
title_full The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians
title_fullStr The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians
title_full_unstemmed The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians
title_short The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians
title_sort tolerability of single low dose primaquine in glucose 6 phosphate deficient and normal falciparum infected cambodians
work_keys_str_mv AT dysoleyl thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians
AT kims thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians
AT lopess thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians
AT khimn thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians
AT bjorgess thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians
AT tops thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians
AT huchc thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians
AT rekolh thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians
AT westercampn thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians
AT fukudam thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians
AT hwangj thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians
AT rocafeltrera thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians
AT mukakam thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians
AT menardd thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians
AT taylorw thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians
AT dysoleyl tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians
AT kims tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians
AT lopess tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians
AT khimn tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians
AT bjorgess tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians
AT tops tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians
AT huchc tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians
AT rekolh tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians
AT westercampn tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians
AT fukudam tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians
AT hwangj tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians
AT rocafeltrera tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians
AT mukakam tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians
AT menardd tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians
AT taylorw tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians